Recommendations for reporting morbid events after heart valve surgery

Area of Science:

• Cardiovascular Surgery
• Clinical Trials Methodology
• Health Outcomes Research

Background:

• Heterogeneity in heart valve surgery results stems from inconsistent follow-up techniques, reporting systems, and adverse event classification.
• Lack of standardized methods hinders the comparison of data across different studies and the analysis of pooled data.
• Improved harmonization is essential for reliable evaluation of surgical outcomes and patient well-being.

Framework:

• Proposes a grading system for follow-up techniques, categorizing them as 'excellent,' 'sufficient,' or 'inappropriate' based on data collection methods and verification.
• Recommends a severity-based scoring system for complications, including specific categorizations for embolisms (using performance status scale) and bleeding events (fatal, major, minor).
• Suggests a 'not categorized' option for unclear embolic or hemorrhagic events and emphasizes reporting antithrombotic management quality alongside morbid events.

Implementation:

• Adoption of standardized follow-up protocols to ensure consistent data collection.
• Systematic application of the proposed grading and scoring systems for adverse events.
• Integration of antithrombotic management quality reporting into adverse event documentation.

Implications:

• Enhances the comparability and reliability of heart valve surgery research findings.
• Facilitates more accurate pooled data analysis, leading to evidence-based practice improvements.
• Ultimately aims to improve patient care and outcomes through more robust clinical research.